The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every ...

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth watching before buying.

Grail (GRAL) is jumping for a second straight day, climbing 6% today, after Oracle (ORCL) Chairman Larry Ellison on Tuesday said that blood tests that detect small tumor fragments could be used, in ...

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

Kanishk Gaur: AI-powered blood tests, such as liquid biopsies, can identify cancerous cells and genetic sequences, allowing for personalized treatment plans. These non-invasive tests are ...

The United States has taken another step toward cementing its leadership in artificial intelligence (AI) with the announcement of an ambitious $500 billion project spearheaded by President Donald ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Samsung Galaxy S25 series pre-orders. Google Gemini-based AI agent. LG Premium soundbars launched. New Galaxy AI features. YouTube Premium experimental features ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...